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Analysis of the Relationship between Viral
Infection and Autoimmune Disease
press a viral protein in a relevant target tissue develop
autoimmune disease after viral infection (Hemmer et al.,
1997; Wucherpfennig and Strominger, 1995; Ohashi et
Vily Panoutsakopoulou,1,2,5 Marie E. Sanchirico,1,2,5
Katharina M. Huster,1,2 Marianne Jansson,1,2
Francesca Granucci,1,6 David J. Shim,1
Kai W. Wucherpfennig,1,3 al., 1991). Cross-reactive T cell activation (mimicry) has
also been implicated in the pathogenesis of Lyme dis-and Harvey Cantor1,2,4
1 Department of Cancer Immunology and AIDS ease (Gross et al., 1998) and a murine model of heart
disease (Bachmaier et al., 1999).Dana-Farber Cancer Institute
2 Department of Pathology The issue of self-mimicry by microbial agents has
been studied in murine Herpes Stromal Keratitis (HSK),3 Department of Neurology
Harvard Medical School a T cell-dependent autoimmune response that destroys
corneal tissue after HSV-1 KOS infection (Avery et al.,Boston, Massachusetts 02115
1995; Streilein et al., 1997). Viral mimicry may provoke
this disorder because Th1 cell clones that initiate HSK
respond to both a corneal self-antigen and a peptideSummary
derived from the UL6 protein of HSV-1 KOS. Moreover,
a replication-defective HSV-1 KOS virus that does notThe clinical association between viral infection and
express the UL6 protein fails to induce HSK in adoptiveonset or exacerbation of autoimmune disorders re-
hosts given virus-immune T cells (Zhao et al., 1998).mains poorly understood. Here, we examine the rela-
However, the inability of this replication-defective mu-tive roles of molecular mimicry and nonspecific in-
tant to induce disease compared with a glycoproteinflammatory stimuli in progression from infection to
B-deficient strain may have reflected a difference inautoimmune disease. Murine herpes virus 1 (HSV-1
virulence between the two deletion mutants and/or in-KOS) infection triggers T cell-dependent autoimmune
hibitory effects of low levels of UL6 expressed at thereactions to corneal tissue. We generated an HSV-1
protein level by the replication-defective virus.KOS point mutant containing a single amino acid ex-
A direct test of the contribution of an HSV-1 peptidechange within the putative mimicry epitope as well
mimic to the development of disease after viral infectionas mice expressing a TCR transgene specific for the
depends on generation of a replication-competent virusself-peptide mimic to allow dissection of two patho-
containing a single amino acid exchange that alters thegenic mechanisms in disease induction. These experi-
putative mimicry epitope and analysis of mice that ex-ments indicate that viral mimicry is essential for dis-
press a TCR transgene (C1-6) specific for a potentialease induction after low-level viral infection of animals
viral mimic (Zhao et al., 1998). We find that this exchangecontaining limited numbers of autoreactive T cells,
virtually abrogates disease induction, while disease sus-while innate immune mechanisms become sufficient
ceptibility is increased dramatically in mice expressingto provoke disease in animals containing relatively
the C1-6 TCR. This mutant virus and TCR transgenichigh numbers of autoreactive T cells.
mouse model are used to delineate the relative contribu-
tion of antigen-specific and innate immune mechanismsIntroduction
to the pathogenesis of autoimmune disease after viral
infection.Two general explanations have been put forward to ex-
plain the clinical association between microbial infection
Resultsand induction or exacerbation of autoimmune disease.
One mechanism depends on evidence that the immune
Generation of a Replication-Competent HSV-1 KOSresponse to pathogens provides a nonspecific stimulus
Mutant Containing a Single Amino Acid Exchangeof the innate immune system that promotes activation
A previous comparison of several replication-defectiveand expansion of autoreactive T cells (Horwitz and Sar-
HSV-1 mutants suggested that expression of the UL6vetnick, 1999). A second holds that the pathogen itself
protein was important for induction of HSK followingmay provide a counterfeit antigenic stimulus that pro-
HSV-1 infection (Zhao et al., 1998). However, impairedvokes autoreactive T cells (Oldstone, 1987; von Herrath
replication or other functional defects of the HSV-1 KOS/and Oldstone, 1996). The contribution of nonspecific
UL6m-mutant virus might have contributed to its failureinflammatory mechanisms has received extensive ex-
to induce disease. A decisive test of the putative UL6-perimental support in several different animal models
derived peptide mimic requires generation of a UL6of autoimmune disease (Horwitz and Sarvetnick, 1999).
amino acid exchange mutant that alters the UL6 T cellThe role of antigenic mimicry has also received exten-
epitope but spares HSV-1 replication and function.sive support. For example, viral peptides can cross-
A mutation that converts the UL6 Ser at position 309stimulate autoreactive human T cells, and mice that ex-
to Leu (S309L) and disrupts the predicted class II binding
frames of the postulated mimic was induced by an alter-4 Correspondence: harvey_cantor@dfci.harvard.edu
ation of AGC (encoding Ser) to CTT (encoding Leu) after5 These authors contributed equally to this work.
site-directed mutagenesis (Figure 1A). The HindIII re-6 Present address: Department of Biotechnology and Bioscience,
University of Milan, Milan, Italy. striction site created by this mutation was used to moni-
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Figure 1. Generation and Analysis of KOS/
UL6S309L
(A) Two potential binding motifs for the UL6
peptide (aa 298–314; TASVKVLLGRKSDS
ERG), based on preferred amino acid anchors
and the I-Ad crystal structure (top). The intro-
duction of an AGC→CTT mutation in an epi-
tope-coding region of the UL6 gene in HSV-1
KOS creates a HindIII site at bp 922 (middle).
Viral DNA extracted from Vero cells infected
with isolates of wild-type KOS or the mutant
KOS/UL6S309L (1,48) was used as template for
PCR amplification of a 1.2 kb fragment of UL6
(bottom), which was gel purified and digested
to test for the presence of the HindIII site
within the epitope coding region (480 and 740
bp for wild-type and 480, 470, and 270 bp for
KOS/UL6S309L).
(B) KOS/UL6S309L replicates at the same rate
as wild-type KOS. Vero cell monolayers were
infected with ten viral particles of KOS (closed
circles) or KOS/UL6S309L (open circles) per cell
and harvested at 18, 27, 37, and 42 hr post-
infection (left). Samples were analyzed for vi-
rus yields as described (Sandstrom et al.,
1986). Data points represent the mean of du-
plicate samples. Viral titers in eyes of infected
mice during the period of acute replication
(right). C.AL-20 mice were ocularly infected
with 4  106 PFU wild-type KOS (closed cir-
cles) or KOS/UL6S309L (open circles); eyes were
harvested on days 2, 3, 4, 5, and 6 and as-
sayed for viral particles as described (Sand-
strom et al., 1986). Data points represent the
mean of duplicate samples.
(C) The T cell response to the KOS/UL6S309L
is similar to the response to wild-type KOS.
DTH response to KOS/UL6S309L. (Left panel)
C.AL-20 mice were infected in the right eye
with either HSV-1 KOS or KOS/UL6S309L (4 
106 PFU), and, 5 days later, individual groups
of infected mice were challenged in the left
footpad with 5  107 PFU UV-inactivated
HSV-1 KOS (white bars) or KOS/UL6S309L
(black bars). The right and left footpads of
each mouse were measured 24 hr later, and
the data are given as average specific swell-
ing calculated by subtracting the width of the
control right footpad of four mice per group.
(Right panel) In vitro proliferation to KOS/
UL6S309L. The right superficial cervical draining
lymph nodes of C.AL-20 mice were harvested
15 days after ocular infection of the right eye
with 4  106 PFU HSV-1 KOS or KOS/UL6S309L. Cells from these lymph nodes were cultured with syngeneic BALB/c irradiated spleen cells in
the presence of UV-inactivated HSV-1 KOS (white bars) or KOS/UL6S309L (black bars). Results are shown as cpm of incorporated [3H]thymidine
that was added to each well during the last 16 hr of culture.
tor recombination after cotransfection of Vero cells with Characterization of the T Cell Response
to Mutant Virus KOS/UL6S309La linear S309L DNA fragment and infectious nonreplicat-
ing KOS/UL6m DNA (containing a stop codon in the UL6 KOS/UL6S309L grew to titers that were at least as high as
wild-type (wt) KOS, and the replication rate of KOS/gene) (Figure 1A). Recombination between linear S309L
DNA and purified KOS/UL6m DNA allows viral replication UL6S309L was indistinguishable from KOS wt after infec-
tion of Vero cells in vitro or murine cornea in vivo (Figureand functional selection of recombinants containing re-
paired UL6 genes. Replication-competent viral isolates 1B). The effect of this amino acid exchange on the ability
of the mutant virus to interact with T cells was also(48) were subcloned after cotransfection, and all con-
tained the S309L mutation according to PCR amplifica- measured. T cells from lymph nodes draining HSV-1
KOS- or HSV-1 KOS/UL6S309L-infected corneas re-tion and HindIII digestion (Figure 1A). Sequencing of the
PCR product containing the epitope region was per- sponded equally well to wt KOS or mutant KOS/UL6S309L,
according to [3H]thymidine incorporation (Figure 1C).formed to confirm conversion of AGC to CTT in two
isolates used for further study. Infection with HSV-1 KOS or KOS/UL6S309L also provoked
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Figure 2. HSK Induction by KOS/UL6S309L
The right eyes of C.AL-20 mice were infected with HSV-1 wild-type
KOS at 4 104 PFU (open circles), 4 105 PFU (plus symbols within
circles), or 4  106 PFU (closed circles) or KOS/UL6S309L at 4  105
PFU (plus symbols within squares), 4  106 PFU (closed squares),
or 4  107 PFU (x within squares), followed by disease assessment
on days 0, 7, 10, and 14 after infection. The percentage of each
group with detectable disease (i.e., incidence [%]) on days 0, 7, 10,
and 14 (minimum score 1) and disease severity shown is based on
analysis of HSK in four to eight mice per data point.
similar levels of tuberculin-type delayed-type hypersen-
sitivity (DTH) upon challenge with either UV-inactivated
KOS or KOS/UL6S309L (Figure 1C). Since the UL6 mutation
did not inhibit the ability of the virus to replicate, interact
with T cells, or induce DTH (cellular) immunity, we were
able to ask whether the local inflammatory response Figure 3. HSK Induction by the KOS/UL6S309L Mutant
provoked by a virus lacking a putative mimic epitope (A) Histologic analysis of the inflammatory response of C.AL-20
(HSV-1 KOS/UL6S309L) caused HSK. mice. After ocular infection by HSV-1/KOS (white bars) and S309L
mutant (black bars); infected eyes were fixed at the indicated days
after infection, sectioned, and stained with hematoxylin-eosin. Infil-
HSK Induction by KOS/UL6S309L trating cells per field (400) were counted (standard error shown).
Numbers indicate average of five fields. *, p  3  105; **, p Corneal infection with 4  104 PFU wild-type KOS was
0.008.sufficient to induce HSK. However, KOS/UL6S309L did not
(B) Adoptive transfer of HSK by CD4 cells from mice infected withinduce detectable HSK in concentrations less than 4 
KOS or KOS/UL6S309L. The right eyes of C.AL-20 mice were infected107 PFU (Figure 2). Thus, an amino acid exchange that with 4  106 PFU/eye of wild-type KOS or the KOS/UL6S309L mutant
affected the UL6 T cell epitope but not other viral func- virus. After infection (7 days), CD4 T cells were isolated (as de-
tions decreased the efficiency of disease induction by scribed in Experimental Procedures) from the draining lymph nodes
of these mice, and 106 CD4 cells from KOS-infected (circles) or KOS/approximately 103-fold compared to wild-type KOS vi-
UL6S309L-infected (squares) mice were transferred intravenously intorus. Histologic analysis of corneas from mice infected
syngeneic BALB/c-RAG2/ mice. After T cell transfer (2 days), recip-with 4  106 PFU KOS wt or KOS/UL6S309L revealed that
ient mice were ocularly infected with 4 105 PFU/eye of either KOSboth viruses provoked similar levels of inflammatory re- (open circles, open squares) or KOS/UL6S309L (closed circles, closed
sponse 5 days after infection (Figure 3A) during the pe- squares) virus and scored for disease on days 7 and 12 as described
riod of active HSV-1 expression (the virus is no longer in Experimental Procedures. Each point represents at least six mice.
detectable in the cornea at the RNA or protein level after
day 6) (Daheshia et al., 1997). The KOS/UL6S309L-induced
Immunity
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inflammatory response diminished and resolved over the T cell clones that recognize the C1-6 peptide (Avery
et al., 1995; Zhao et al., 1998). A direct test of this hypoth-the next 10 days, while the KOS-induced inflammatory
response progressively increased during this time in the esis comes from an analysis of HSK induction in the
resistant C.B-17 mouse strain that expresses the C1-6absence of detectable HSV-1.
TCR transgene. We find that the C.B-17 C1-6 TCR tg
mice develop severe HSK following HSV-1 KOS infectionAdoptive Transfer of HSK by CD4 Cells
(4 105 PFU), while age- and sex-matched control C.B-from KOS/UL6S309L-Infected Mice
17 mice do not develop detectable disease (Figure 4A).We then defined the ability of the S309L mutant virus
Thus, insertion of the C1-6 TCR into the T cell repertoireto stimulate pathogenic CD4 cells according to transfer
converts the phenotype of C.B-17 mice from resistantof HSK. CD4 cells from donors infected with KOS/
to highly susceptible.UL6S309L were unable to transfer detectable HSK to RAG-
2/ recipients challenged with wt KOS in contrast to
CD4 cells from donors infected with wt KOS, which re- Amelioration of HSK Using V Antibody or Peptides
One prediction of these data is that purging of CD4 cellsproducibly transferred robust HSK into RAG-2/ recipi-
ents upon infection with HSV-1 KOS (Figure 3B). The containing the pathogenic V8V11 TCR from the T
cell repertoire might ameliorate HSK upon viral infection.103-fold reduction in HSK activity of the KOS/UL6S309L
virus and its failure to induce pathogenic CD4 cells indi- We found that depletion of V8.1/8.2 cells but not V6
cells from C.AL-20 mice markedly reduced disease in-cate that the UL6 viral mimic critically contributes to
activation and expansion of T cells that initiate this auto- tensity after corneal infection with HSV-1 KOS without
affecting the T cell response to HSV-1 (Figures 4B andimmune disease.
4C). Moreover, removal of V8 but not V6 cells from
CD4 cells infused into BALB/c-RAG2/ hosts virtuallyInitiation of HSK by CD4 Cells Bearing
eliminated their ability to transfer HSK into adoptivethe C1-6 TCR
hosts (Figure 4B). Depletion of V8 CD4 cells did notThese findings suggest that CD4 T cells that express
affect antiviral activity, because RAG-2/ recipients ofa TCR that recognizes the UL6 mimic and a corneal
V8-depleted CD4 cells were fully protected from theautoantigen can initiate HSK after viral infection. We
lethal HSV-1 encephalitis that routinely follows ocularhave previously defined a V8V11CD4 T cell clone
infection of mice that are deficient in T cells (Altmann(C1-6) that expressed this pattern of crossreactivity and
and Blyth, 1985). Moreover, T cells from mice treatedtransferred HSK into syngeneic RAG-2/ hosts (Zhao
with V8 antibody displayed unimpaired proliferative re-et al., 1998). We therefore expressed the C1-6 or control
sponses to HSV-1 in vitro (Figure 4C). These data extendDO11.10 TCR (which recognizes an OVA-derived pep-
conclusions drawn from analysis of C1-6 TCR transgenictide) transgene in BALB/c-RAG2/ mice to generate
mice concerning the primacy of V8 C1-6 TCR in“monoclonal” mice that do not contain other T cell
disease induction and suggest new therapeutic ap-clones because of a blocked endogenous TCR recombi-
proaches based on depletion of a restricted portion ofnation (Chen et al., 1993a, 1993b) to directly test the
the T cell repertoire.contribution of this TCR to disease.
A second consequence of the view that C1-6 TCRT cells that develop in BALB/c-RAG2/ C1-6 TCR Tg
CD4 cells play a critical role in disease induction is thatmice are composed entirely of V8CD4 T cells (as
engagement of this TCR by a peptide ligand leading topredicted from the class II reactivity of the C1-6 TCR)
anergy or apoptosis should inhibit disease development(data not shown), and ocular infection by 103 PFU HSV-1
in vivo. The peptide SYFMYSKLRVQKS represents aKOS provoked HSK in all BALB/c-RAG-2/ C1-6 mice.
superagonist that efficiently activates the C1-6 T cellIn contrast, a 104-fold increase in viral titer to 107 PFU
clone at concentrations of less than 0.05 M (Zhao et(the highest titer technically feasible) failed to induce
al., 1998) and, at concentrations greater than 20 M,detectable HSK in BALB/c-RAG-2/ DO11.10 mice (Ta-
induces CD4 cells from C1-6 TCR transgenic mice toble 1A). Histologic analysis of the inflammatory response
undergo anergy and apoptosis (Figures 5A and 5B). Weat day 10 showed a substantial mononuclear cell infiltra-
therefore asked whether this ligand might induce resis-tion of the corneas of BALB/c-RAG-2/ C1-6 mice
tance to HSK in both C1-6 TCR and in susceptible (non-(69.8 13/hpf) but virtually none in the corneas of BALB/
transgenic) C.AL-20 mice. Intravenous injection of highc-RAG-2/ DO11.10 mice (3  1.8/hpf).
concentrations of soluble C1-6 (400 g/mouse) but notIncreased HSK susceptibility of BALB/c-RAG-2/
a mutant peptide that no longer activates the C1-6 TCRC1-6 mice reflected enhanced T cell reactivity because
resulted in almost complete resistance to the develop-2  104 CD4 cells from BALB/c-RAG-2/ C1-6 mice
ment of HSK after infection with HSV-1 (Figure 5C).transferred HSK to naive BALB/c-RAG-2/ hosts, while
2 106 CD4 cells from nontransgenic BALB/c mice were
required for efficient transfer of HSK, and as many as Role of Antigen-Specific and Inflammatory
Stimuli in the Induction of HSK2 107 CD4 cells from BALB/c-RAG-2/ DO11.10 mice
failed to transfer detectable disease (Table 1B). These The finding that RAG-2/ hosts reconstituted with KOS-
primed CD4 cells developed mild but significant diseasedata indicate that small numbers of CD4 cells that ex-
press the C1-6 TCR are sufficient to confer disease while when challenged with KOS/UL6S309L (Figure 3B) opened
the possibility that LPS-induced stimulation of innatemuch larger numbers of T cells bearing an irrelevant
TCR cannot. immunity and APC may induce disease in hosts con-
taining sufficient numbers of autoreactive T cells. ToWe have previously suggested that mouse strains that
are resistant to HSK following HSV-1 KOS infection lack test this hypothesis, we examined a series of mice that
Viral Infection and Autoimmune Disease
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Table 1. Analysis of HSK after Ocular Infection of BALB/c-RAG-2/ Cl-6 Transgenic Mice
Herpes Stromal Keratitis
A. Mouse Strain HSV-1 Challenge (PFU/Eye) Percent Severity
C.AL-20 4  103 0 0
4  104 100 2.7
4  105 100 3.3
BALB/c-RAG-2/ Cl-6 tg 4  102 20 0.5
4  103 100 2.1
4  104 100 3.2
4  105 100 4.0
BALB/c-RAG-2/ DO11.10 tg 4  106 0 0
4  107 0 0
B. CD4 Cell Donor Disease Incidence (%): CD4 Cells Infused into RAG-2/ Hosts
2  104 2  105 2  106 2  107
BALB/c-RAG-2/ Cl-6 tg 100 100 100 100
BALB/c-RAG-2/ DO11.10 tg 0 0 0 0
BALB/c 0 20 90 100
(A) Mice were infected with HSV-1 KOS in the right eye, and disease was scored on day 10 and 14 after infection, as described in Experimental
Procedures. The percentage of each group with detectable disease on day 14 (minimum score 1) and disease severity shown is based on
analysis of HSK in four to eight mice per data point. (B) Purified CD4 cells from BALB/c, BALB/c-RAG-2/ Cl-6 TCR Tg, or BALB/c-RAG-
2/ DO11.10 TCR Tg were adoptively transferred into BALB/c-RAG-2/ mice. Recipient mice were infected with 4  105 PFU/eye HSV-1
KOS and scored for HSK. The percentage of each group with detectable disease on day 14 (minimum score 1) shown is based on analysis
of HSK in five to eight mice per data point.
contained increasing numbers of autoreactive T cells relative importance of antigen-specific stimuli (microbial
mimics) and nonspecific innate immune mechanisms to(naive C.AL-20; 	KOS-immune C.AL-20; BALB/c-RAG-
2/ C1-6; 	KOS-immune BALB/c-RAG-2/ C1-6). the genesis of autoimmune disease, in part because
both mechanisms are likely to contribute to most auto-While inoculation of LPS or infection by the HSV-1 KOS/
UL6S309L mutant virus onto scratched corneas fails to immune disorders, while one or the other may play a
dominant role under particular circumstances (Cantor,cause disease in naive C.AL-20 or BALB/c mice, 60%
of KOS-immune C.AL-20 mice developed HSK after in- 2000). Our studies delineate the conditions that deter-
mine the importance of these two mechanisms to theoculation of LPS into the cornea. Moreover, 100% of
BALB/c-RAG-2/ C1-6 transgenic mice but not control development of HSK.
BALB/c-RAG-2/ DO11.10 mice developed intense ker-
atitis after inoculation of LPS or infection with KOS/ Viral Infection and Molecular Mimicry
UL6S309L (Figures 6A and 6C). Finally, provision of a mild The HSK system is particularly well-suited for studying
inflammatory stimulus (corneal scratch) induced severe the inciting role of viral infection, because stimulation
keratitis in BALB/c-RAG-2/ C1-6 mice that had been of the immune system by the virus is limited to an acute
immunized with UV-inactivated HSV-1 (Figure 6B). period of approximately 5–7 days, after which the virus
These experiments indicate that (1) direct activation of becomes undetectable at the protein and RNA level
T cells by the molecular mimic is required to induce (Streilein et al., 1997; Figure 1), in contrast to other viral
disease in normal nonprimed animals containing limiting infections that may provoke chronic immune reactions
numbers of autoreactive T cells (naive C.AL-20); and through smoldering infection (e.g., HSV-1 encephalitis).
(2) innate immune mechanisms are sufficient to trigger A direct test of a peptide mimic in HSK induced by HSV-1
disease in animals that contain expanded numbers of KOS comes from analyses of a replication-competent
C1-6 TCR T cells. Moreover, development of intense KOS point mutant as well as studies of mice that express
HSK in BALB/c-RAG-2/ C1-6 but not DO11.10 trans- a TCR specific for this mimic. The S309L amino acid
genic mice after LPS-dependent activation of innate im- exchange in the HSV-1 KOS UL6 protein alters the pre-
mune mechanisms reemphasizes the autoimmune na- dicted UL6 T cell epitope without affecting viral replica-
ture of HSK in this model. tion, stimulatory activity for T cells, or induction of DTH
and is thus equipped to provide an unimpaired inflam-
matory milieu (Figure 1). Nevertheless, this viral mutantDiscussion
did not cause HSK in susceptible C.AL-20 mice unless
viral concentrations were increased 103-fold, achievingMicrobial infection often precedes the clinical onset of
diabetes (Gamble and Taylor, 1973; Gamble, 1980; Na- levels not normally seen in nature (Figure 2). Histologic
analysis of the cornea showed that cellular infiltrationgata and Yoon, 1992) and relapses of multiple sclerosis
(Sibley et al., 1985) and can precipitate murine diabetes after KOS/UL6S309L and wt KOS infection was similar at
day 5, when virus was present. However, over the next(Nagata and Yoon, 1992), demyelinating disease (Rodri-
guez et al., 1987; Dal Canto and Rabinowitz, 1982; Miller 10 days, when the virus is no longer detectable, cell
infiltration initiated by wt virus progressively increased,et al., 1990), herpes stromal keratitis (Streilein et al.,
1997; Zhao et al., 1998), and myocarditis (Bachmaier et while the KOS/UL6S309L virus-initiated cellular response
was markedly reduced by day 10 and absent at day 15.al., 1999). However, there is no consensus view of the
Immunity
142
Figure 4. Regulation of HSK Response to HSV-1/KOS by the
C1-6 TCR Figure 5. Effect of a Peptide Superagonist on C1-6 T Cell Re-
(A) Effect of C1-6 TCR transgene. C.B-17 (open circles) and C.B-17 sponses
C1-6 TCR transgenic (closed circles) mice were infected with HSV-1 (A) Stimulation of CD4 cells from BALB/c-RAG-2/ C1-6 mice in
(KOS; 4  105 PFU). Data shown represent two independent experi- vitro. Proliferative response of CD4 cells from BALB/c-RAG-2/
ments based on analysis of four to five mice per group. C1-6 mice (104/well plus 105 irradiated BALB/c splenic cells) to the
(B and C) Depletion of V T cell subpopulation and HSK. (B) (Left indicated concentrations of peptide: C1-6 (292-308; SYFMYSK
panel) C.AL-20 mice were depleted in vivo of V6 cells (open circles) LRVQKS) (closed circles) or K8S mutant (SYFMYSKLRVQSS) (open
and V8 cells (closed circles) by i.p. injection of monoclonal anti- circles), as described in Experimental Procedures.
bodies (four doses of 25 g each), resulting in 98%–99% depletion, (B) Induction of unresponsiveness by C1-6 peptide. After stimulation
or untreated (open squares), before ocular infection with HSV-1 KOS (5 days) of C1-6 CD4 cells (5  104/well) with the indicated concen-
(4  106 PFU/eye). (Right panel) Purified CD4 cells from BALB/c trations of the C1-6 peptide, cells were restimulated with immobi-
mice were transferred (3  106/mouse) into BALB/c-RAG2/ mice lized anti-CD3 (5 g/ml; black bars) or C1-6 peptide (100 M; white
after in vitro depletion (99%) of V6 cells (open circles) or V8 bars) and [3H]thymidine incorporation was determined 24–36 hr later.
cells (closed circles) or untreated (open squares). All mice were The levels of apoptosis as judged by annexin staining 24 hr after
ocularly infected 24 hr later with HSV-1 KOS (4  106 PFU/eye) anti-CD3 stimulation of cells primed with 0, 20, and 200 M peptide
followed by disease assessment as described in Experimental Pro- were 11, 74, and 82, respectively.
cedures. HSK index percent incidencemean severity of clinical (C) Effect of soluble C1-6 peptide on HSK. BALB/c-RAG2/ C1-6
stromal keratitis 
 10. Each data point represents the average of TCR Tg and C.AL-20 mice were intravenously injected (400 g/
at least five mice. mouse) with either normal C1-6 (open circles) or a mutant C1-6
(C) The lymph nodes of HSV-1 KOS-infected, V6-depleted (hatched peptide, K8S (closed circles) twice prior to ocular infection with
bars), V8-depleted (black bars), or untreated (white bars) C.AL-20 HSV-1 (4  106 PFU/eye), and HSK was scored on the indicated
mice were harvested and cultured with syngeneic C.AL-20 irradiated days.
spleen cells in the presence of UV-inactivated HSV-1 KOS (as de-
scribed in Experimental Procedures). Results are shown as cpm of
incorporated [3H]thymidine that had been added to each well during
the last 16 hr of culture.
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Figure 6. Nonspecific Stimuli Induces Kerati-
tis in Mice Containing Large Numbers of Self-
Reactive T Cells
(A) The right eyes of BALB/c-RAG2/ (open
circles), BALB/c-RAG2/ DO11.10 Tg (closed
squares), or BALB/c-RAG2/ C1-6 TCR Tg
(closed circles) mice were scratched with a
27 gauge needle, and 16 g of LPS (Sigma,
St. Louis, MO) was added in an 8 l volume.
Clinical keratitis was scored on day 5, 7, 10,
and 15. Each point represents at least eight
mice.
(B) BALB/c-RAG2/ C1-6 TCR Tg (closed cir-
cles) and BALB/c-RAG2/ DO11.10 TCR Tg
(open circles, closed squares) mice were im-
munized three times with 2  109 PFU irradi-
ated KOS virus weekly prior to ocular scarifi-
cation or scarification and LPS (16 g)
treatment. Clinical keratitis was scored on
day 3, 7, and 12. Each point represents at
least five mice per group.
(C) The indicated strains were infected with
increasing titers of HSV-1 (KOS or S309L) in
the right eye, and disease was scored on day
10 after infection, as described in the Experi-
mental Procedures. The percent with detect-
able disease on day 10 (minimum score 1) is
shown based on analysis of four to eight mice
per group.
This truncated response reflected the inability of KOS/ Viral Infection and Innate Immunity
Understanding the conditions that determine the contri-UL6S309L to stimulate disease-inducing T cells; purified
CD4 T cells from the draining lymph nodes of KOS/ bution of innate and adaptive immune mechanisms to
the pathogenesis of autoimmunity following infectionUL6S309L-infected mice were unable to transfer significant
disease to recipient BALB/c-RAG2/ mice compared remains a central and unresolved issue in this field (Hor-
witz and Sarvetnick, 1999; Medzhitov and Janeway,with the robust activity of CD4 cells from KOS-wt-
infected mice (Figure 3B). 1998). The role of nonspecific inflammatory responses is
most clearly evident from the finding that tissue-specificComparative analyses of HSK after HSV-1 infection
of RAG-2/ mice expressing the C1-6 and DO11.10 TCR expression of cytokine transgenes can provoke auto-
immune disease without the need for microbial infectionstrengthened the conclusion that HSK induction after
HSV-1 (KOS) infection depended on activation of a re- (Horwitz et al., 1997; Akassoglou et al., 1997). In most
cases, microbial infection increases the efficiency of Tstricted set of CD4 clones. This hypothesis also received
support from the finding that insertion of the C1-6 TCR cell activation through enhanced expression of costimu-
latory molecules, upregulation of MHC expression oninto the T cell repertoire converted the phenotype of
C.B-17 mice from resistant to highly susceptible. The professional APC, and attraction of dendritic cells from
peripheral to secondary lymphoid tissues (Bachman ethypothesis that the interaction between the C1-6 TCR
and the viral mimic played a critical role in disease induc- al., 1997). Continued activation of innate immunity can
also potentiate autoimmune disorders through chroniction predicted several targeted approaches to immuno-
therapy of the disease. We found that depletion of V8.1/ immune-mediated tissue damage and autoantigen re-
lease without the need for specific activation of auto-8.2 cells (the V expressed by C1-6) but not V6 cells
markedly diminished disease intensity after corneal in- reactive T cells by a microbial mimic (Miller et al., 1990,
1995, 1997; Vanderlugt, 1996; Vanderlugt et al., 1998).fection with HSV-1 KOS without affecting the overall
antiviral immune response and that intravenous injection We have compared the relative importance of inflam-
matory and antigen-specific aspects of infection ac-of a C1-6 peptide at concentrations that induce apo-
ptosis in vitro ameliorated disease in vivo (Figures 5 cording to the level of autoreactive T cells in the host.
A mild inflammatory stimulus (corneal trauma) is suffi-and 6).
Immunity
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cient to provoke disease in animals containing high lev- logs that bind well to self-MHC and strongly stimulate
T cells in vitro cause apoptosis of autoreactive T cellsels of autoreactive memory T cells (Figure 6C), while a
and inhibit disease in vivo (Anderton et al., 2001).stronger nonspecific stimulus (mutant KOS/UL6S309L vi-
rus or LPS) elicits disease in mice that harbor high num-
Viral Infection and Bystander Damagebers of naive autoreactive T cells (Figures 6A and 6C).
In all of the above examples, viral infection through spe-Similarly, MBP1-11 TCR transgenic mice spontaneously
cific or nonspecific mechanisms provokes autoreactivedevelop experimental autoimmune encephalomyelitis
T cells and consequent autoimmune tissue destruction.(EAE) after exposure to pertussis toxin without specific
However, two recent studies by Gangappa and cowork-antigen (Goverman et al., 1993; Linthicum et al., 1982;
ers suggest that a strain of HSV-1 (RE) can induce aMunoz et al., 1984). All these observations emphasize
nonautoimmune form of keratitis after infection (Gan-that the need for a specific antigenic stimulus is greatest
gappa et al., 1998, 2000). In the second study (Gangappawhen the host contains limiting numbers of autoreactive
et al., 2000), BALB/c-RAG2/ DO11.10 mice developedT cells, while nonspecific stimuli are sufficient for dis-
keratitis after infection with the HSV-1 RE strain, in ap-ease induction in hosts containing expanded numbers
parent contrast to our findings that these mice do notof autoimmune T cells. These conclusions are also con-
develop HSK after infection by very high titers of HSV-1sistent with observations that Coxsackie B (CB4) virus
KOS (Table 1; Figure 3A). The disparity in these resultsinfection can induce diabetes in BDC2.5 mice provided
reflects a difference in the virulence (Thomas and Rouse,that that host has developed an expanded population
1997) and pathogenicity of the two HSV-1 strains. Weof autoreactive CD4 memory cells (Horwitz et al., 1998;
have noted that, at relatively high concentrations (4 Serreze et al., 2000).
106 PFU), ocular infection by the RE strain can cause
clinical keratitis in up to 50% of BALB/c-RAG2/Molecular Mimicry and Autoimmune Disease
DO11.10 mice, while infection of the same mice withWhy is expression of a molecular self-mimic essential
these titers of HSV-1 KOS fails to induce detectablefor efficient disease induction in hosts containing limited
corneal changes or histological evidence of cellular infil-numbers of autoreactive T cells? The target self-antigen
tration. The pathogenicity of HSV-1 RE in BALB/c-RAG-of HSK is naturally expressed in a nonlymphoid tissue
2/ DO11.10 mice may be related to the ability of thisand may not reach levels sufficient for effective cross-
strain to attract large numbers of neutrophils (Thomas
presentation to autoreactive T cells, even after microbial
et al., 1997), in contrast to KOS, which primarily attracts
infection (Kurts et al., 1998; Ludwig et al., 1999; Sevilla
macrophages (Hendricks and Tumpey, 1990), and to its
et al., 2000; Serreze et al., 2000). Viruses, on the other persistence at higher titers in the corneas of immuno-
hand, are efficiently taken up by professional APC, and competent mice (Su et al., 1990), leading to attendant
peptides derived from them rapidly gain the direct atten- damage of the cornea through release of collagenases
tion of T cells. Presentation of a viral peptide mimic thus and/or necrosis of the local vasculature. Alternatively,
bypasses the series of events beginning with release of the intense inflammatory response provoked by the RE
autoantigen from dying cells and ending with uptake, virus may allow recognition of low-affinity viral mimics
processing, and cross-presentation by local APC (Ehl by the DO11.10 TCR.
et al., 1997; Oxenius et al., 1998). The resulting gain in The development of blindness following clinical her-
immunogenicity is reminiscent of the enhanced T cell petic stromal keratitis is marked by intense stromal in-
response achieved after bypassing the need for cross- flammation leading to irreversible corneal scarring, glau-
presentation through expression of tumor antigens in coma, and cataract. Infection of the mouse strains used
dendritic cells (Klein et al., 2000). here with HSV-1 KOS or RE strains, which model the
These data open the possibility that subclinical infec- most destructive and blinding form of this clinical disor-
tion by a virus that expresses a mimic can “prime” the der, supports two distinct pathogenic pathways. Infec-
host for an autoimmune response upon infection of the tions by relatively nonpathogenic HSV-1 strains such
target organ by an unrelated virus, thus complicating as KOS are translated into an autoimmune attack and
the search for viral mimics associated with clinical dis- blindness through the expression of a viral mimic. A
ease. These studies also highlight the importance of second pathway may result from infection by HSV-1
testing for viral mimicry early in life (e.g., in genetically strains such as RE, which lead to proteolysis and colla-
predisposed children), since viruses isolated after the gen breakdown through nonautoimmune mechanisms
onset of clinical disease, such as the dozens identified that may include bystander damage. Elucidation of the
in MS patients, are likely to contribute to disease patho- relative roles of these two pathogenic pathways in clini-
genesis through their effects on innate rather than spe- cal HSK represents the next step in diagnosis and treat-
cific immunity. Our studies also indicate that screening ment of a leading cause of human blindness. In a broader
for peptide mimics should include assessment of rela- context, our studies suggest approaches for evaluation
of the relative roles of antigen mimicry and nonspecifictively weak microbial ligands. Although the UL6 peptide
inflammation in a variety of clinical syndromes, rangingepitope has a relatively low-affinity interaction with the
from bacterial arthritis to some forms of atherosclerosisC1-6 TCR, it is sufficient to induce disease in vivo, while
(Gross et al., 1998; Bachmaier et al., 1999).the high-affinity C1-6 peptide (which efficiently stimu-
lates T cells in vitro) inhibits rather than enhances dis-
Experimental Proceduresease in vivo (Figures 4A and 5A). These findings are
congruent with the recent observation that MBP-derived Mice
peptides that display low-affinity binding to self-MHC C.AL-20 and C.B-17 female mice were purchased from The Jackson
Laboratory (Bar Harbor, ME); DBA/2 and CD1 mice were purchasedefficiently provoke EAE in vivo, while MBP peptide ana-
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from Charles River Laboratory, Inc. (Wilmington, MA); and BALB/c Histology
Mice were sacrificed on day 5, 10, and 15 postinfection, and infectedand BALB/c-RAG2/ mice were purchased from Taconic Labora-
tories, Inc. (Germantown, NY). The OVA-TCR (DO11.10) transgenic eyes were enucleated and immediately frozen before tissue sections
were stained with hematoxylin-eosin and observed for thickness ofmice were crossed into the RAG2/ background (confirmed by PCR
and FACS analysis). All mice used for experimentation were 6–8 cornea and number of infiltrating cells.
weeks of age and housed in microisolator cages in the animal bio-
safety level 2 of the Dana Farber Cancer Institute animal facility.
Construction of the C1-6 TCR Transgenic Mice
The C1-6 TCR transgenic mouse line was created by cloning the 
Construction of KOS/UL6S309L HSV-1 Replication-Competent and  chains from the C1.6 keratogenic T cell clone (Avery et al.,
Mutant Virus 1995). The -rearranged cDNA (800 bp) was amplified by anchored
The mutant UL6S309L allele was constructed using the pZZ plasmid PCR as described (Frohman et al., 1988), cloned into SalI-SmaI-
(Zhao et al., 1998) containing a 1.3 kb segment of UL6 and the digested pSP72 (Promega Corp., Madison, WI) to create 11I, and
Clonetech TransformerTM Site-directed mutagenesis kit to alter UL6 confirmed by sequence analysis. The XhoI-BglII fragment from 11I
codon 309 from AGC encoding Ser to CTT encoding for Leu creating containing the complete coding sequence for the  chain was sub-
plasmid pMES2. These nucleotide changes introduce a HindIII site cloned into the pHSE3 transgenic vector (Pircher et al., 1989), plac-
at bp 922 in the UL6 coding sequence. The 1 kb MluI-SphI fragment ing the  chain under the transcriptional control of the H-2Kb pro-
from pMES2 containing the S309L mutation was subcloned into moter. Similarly, the -rearranged cDNA (930 bp) was amplified
plasmid pMES12, which contains the entire UL6 coding sequence by RT-PCR, cloned into SmaI-HindIII-digested pGEM7zf (Promega
and a large portion of HSV-1 flanking sequence, to create pMES18. Corp.) to create BETAI, and sequenced. The XhoI-BamHI fragment
To integrate the UL6S309L mutation into the HSV-1 KOS genome, 1 from BETAI containing the complete V8.1/D1.1/J1.4/C1 se-
g KOS/UL6m infectious DNA and 5g BstBI-AflII-digested pMES18 quence was subcloned into the pHSE3 vector and placed under
were cotransfected into 1  106 BKK21 cells that had been engi- the control of the H-2Kb promoter. The two XhoI fragments from
neered to express UL6 (Patel et al., 1996). The KOS/UL6m infectious pHSE3 and pHSE3 were used to produce the transgenic mice,
DNA contains a C to T point mutation at nucleotide 136 in the UL6 as described (Hogan et al., 1986). DBA/2 (H-2d)  BALB/c (H-2d)
coding sequence and does not synthesize UL6 protein (Zhao et al., eggs were comicroinjected with  and  chain constructs, implanted
1998). Recombination between the BstBI-AflII UL6S309L fragment from in CD1 females to produce mice with a complete C1-6 TCR. These
pMES18 and the KOS/UL6m infectious DNA introduced the S309L mice were crossed to BALB/c mice for three to four generations
mutation while repairing the UL6m point mutation. before crossing onto the BALB/c-RAG2/ genetic background. The
To identify and purify a replication-competent virus that contains TCR transgene expression and RAG2/ defect were confirmed by
the UL6S309L mutation, the transfected G33 cells were harvested 5 both PCR and FACS analysis.
days after transfection, virus was isolated by three rounds of freeze
thawing, and subsequently used to infect Vero cells. Since KOS/
UL6m cannot replicate in Vero cells, only recombinants with a re- Delayed-Type Hypersensitivity
paired UL6m point mutation could grow. Individual plaques (48) from C.AL-20 mice were infected in the right eye with HSV-1 KOS (4 
the Vero cell infection were purified and screened for the presence 106 PFU), and, 5 days later, individual groups of infected mice were
of the S309L mutation by PCR amplification and digestion with challenged in the left footpad with 5 107 PFU UV-inactivated HSV-1
HindIII enzyme. All 48 of the viruses analyzed carried the mutation. KOS or KOS/UL6S309L (Foster et al., 1986), and the right and left
Sequencing of an extended region (500 bp) flanking the 5 and 3 footpads of each mouse were measured 24 hr later with a Fowler
boundaries of the recombination sites did not reveal any nucleotide micrometer (Schlesinger Tool, Brooklyn, NY).
differences compared with the wild-type sequence.
In Vitro Proliferation to KOS/UL6S309LReplication Curve for KOS/UL6S309L and WT KOS
The right superficial cervical draining lymph nodes of C.AL-20 miceIn vitro
were harvested 15 days after ocular infection of the right eye withTo compare the replication rate of the KOS/UL6S309L mutant virus to
4  106 PFU HSV-1 KOS or KOS/UL6S309L. Cells from these lymphwild-type KOS, 2  105 Vero cells were seeded in wheaton glass
nodes (1 105 per well) were cultured with syngeneic BALB/c irradi-vials 4 hr prior to infection with 2  106 PFU of virus followed by
ated (3000 rad) spleen cells (5  105/well) in the presence of 2 incubation (1 hr at 37C) and removal of virus by washing. Cells
107 PFU UV-inactivated HSV-1 KOS or KOS/UL6S309L, as describedwere resuspended in 1 ml of serum-free DMEM medium, and individ-
(Zhao et al., 1998). [3H]thymidine (1 Ci) was added to each wellual vials were removed at the indicated time points, frozen at70C,
during the last 16 hr of culture.and prepared by repeated freezing/thawing before assaying for viral
PFU/ml by standard methods (Sandstrom et al., 1986).
In vivo
Purification of CD4 Cells and Analysis by Flow CytometryC.AL-20 mice were ocularly infected with 4  106 PFU wild-type
CD4 T cells were isolated by magnetic negative selection (Dynal,KOS or KOS/UL6S309L; eyes were harvested on days 2, 3, 4, 5, and
Lake Success, NY) using antibodies to CD8 (53-6.7), B220 (RA3-6 and assayed for viral particles as described (Sandstrom et al.,
6B2), Gr-1 (RB6-8C5), and Mac-1 (M1/70) (PharMingen, San Diego,1986).
CA). For certain experiments, anti-V8 (F23.1) or anti-V6 (RR4-7)
was also used (PharMingen). Cells from lymph nodes or blood were
Ocular Infection and Scoring of HSK stained using FITC- or PE-conjugated anti-V8(8.1/8.2), anti-V6,
Corneas of mice were scarified using a sterile 27 gauge needle anti-V4, anti-V2, and anti-CD4 as previously described (Pestano
(Avery et al., 1995) before infection with HSV-1 (KOS or KOS/UL6S309L) et al., 1999).
in the right eye, and disease severity was scored on different days
after infection as described (Avery et al., 1995), based on the degree
of corneal opacity: 25% of cornea, 1; 50%, 2; 75%, 3; 75%– Depletion of T Cells According to V Expression
Mice were depleted in vivo of V6 cells or V8 cells by intraperito-100%, 4. Corneal opacity represents irreversible and progressive
destruction characteristic of necrotizing keratitis resulting from se- neal injection of monoclonal antibodies (RR4-7 or F23.1; four doses
of 25 g each; day 5, 3, 0, and 2; PharMingen), resulting invere stromal edema and necrosis with ulcerations seen on histologi-
cal sections of the cornea. Neovascularization or corneal clouding 98%–99% depletion (as measured by flow cytometric analysis). De-
pleted mice were ocularly infected with HSV-1 KOS (4  106 PFU/were not used to measure stromal keratitis, since these changes
may be transient and reversible. Incidence of disease is measured eye). In other experiments, purified CD4 cells from BALB/c mice
were transferred (3  106/mouse intravenously) into BALB/as the percentage of mice with a severity score1. In certain experi-
ments, disease score is summarized as “HSK index”  severity c-RAG2/ recipient mice after in vitro depletion by magnetic nega-
tive selection (99% by flow cytometry) of V6 cells or V8 cells.(mean clinical score)  incidence (%) divided by 10.
Immunity
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